Trade Avidity Biosciences Inc - RNA CFD

Add to favourite

31.03

4.41%

0.14

Low: 31.03

High: 32.59

Market Trading Hours* (UTC) Opens on Monday at 14:30

Mon - Fri: 14:30 - 21:00

Summary
Historical Data

Trading сonditions

Spread

0.14

Long position overnight fee

-0.023512%

Short position overnight fee

0.00129%

Overnight fee time

22:00 (UTC)

Min traded quantity

Currency

USD

Margin

50.00%

Stock exchange

United States of America

Commission on trade

Key Stats

Prev. Close	32.46
Open	32.59
1-Year Change	128.22%
Day's Range	31.03 - 32.59

Last Week
Last Month
Last Year
Last two Years
Max

Daily
Weekly
Monthly

Date	Close	Change	Change (%)	Open	High	Low
Feb 21, 2025	31.03	-1.47	-4.52%	32.50	32.94	31.01
Feb 20, 2025	32.46	0.59	1.85%	31.87	33.31	31.01
Feb 19, 2025	31.85	0.19	0.60%	31.66	32.20	31.21
Feb 18, 2025	31.94	-0.39	-1.21%	32.33	32.99	31.86
Feb 14, 2025	32.25	-0.96	-2.89%	33.21	33.86	31.08
Feb 13, 2025	32.92	0.92	2.88%	32.00	32.98	31.75
Feb 12, 2025	31.77	-0.81	-2.49%	32.58	32.60	30.48
Feb 11, 2025	33.74	0.22	0.66%	33.52	34.05	32.75
Feb 10, 2025	34.25	-0.71	-2.03%	34.96	34.96	33.06
Feb 7, 2025	34.87	-0.08	-0.23%	34.95	35.37	34.28
Feb 6, 2025	35.05	0.83	2.43%	34.22	35.17	34.07
Feb 5, 2025	34.62	1.16	3.47%	33.46	34.75	33.26
Feb 4, 2025	33.27	1.57	4.95%	31.70	33.47	31.70
Feb 3, 2025	31.88	0.36	1.14%	31.52	32.71	31.42
Jan 31, 2025	32.88	0.28	0.86%	32.60	33.81	32.34
Jan 30, 2025	32.57	0.68	2.13%	31.89	32.88	31.69
Jan 29, 2025	31.85	-0.04	-0.13%	31.89	32.37	31.39
Jan 28, 2025	32.03	1.67	5.50%	30.36	32.64	29.55
Jan 27, 2025	30.40	1.30	4.47%	29.10	31.72	29.10
Jan 24, 2025	29.62	-0.04	-0.13%	29.66	29.95	29.17

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission

Leverage

2:1

20
100
500
1000
10000

Investment

Trade size (Leverage x Investement):

Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Avidity Biosciences Inc

Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company''s lead product candidate AOC 1001 is used for the treatment of myotonic dystrophy type 1, a rare monogenic muscle disease; and to design, engineer, and develop therapeutics that combine tissue selectivity of monoclonal antibodies and the precision of oligonucleotide therapies to access previously undruggable tissue and cell types, and target underlying genetic drivers of diseases. In addition, it develops muscle programs, which focuses on the treatment of facioscapulohumeral muscular dystrophy, Duchenne muscular dystrophy, muscle atrophy, and Pompe diseases. Avidity Biosciences, Inc. was incorporated in 2012 and is based in La Jolla, California.

News

Microsoft Stock Price Forecast for 2025 and beyond: Third party price target

We assess the likely level of the Microsoft stock price in 5 years, and possible drivers behind the stock’s past performance. Read on...

18:29, 7 February 2025

Ripple XRP price prediction: Third-party price target

Discover the ripple (XRP) price predictions for 2025 and beyond, with analyst price targets and CFDs trading strategies on Capital.com

15:29, 6 February 2025

Apple Store on Fifth Avenue, New York, October 2016

Apple (AAPL) stock price forecast: third-party price target

We looked at the forecasts for Apple stock in 10 years to see where the price would likely be at that point and the challenges the company could face. Read more.

11:22, 6 February 2025